Compare, Analyse Dr. Reddys with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ACTAVIS (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ACTAVIS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
ACTAVIS
Dec-18
DR. REDDYS LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,36314,487-   
Low Rs2,3529,718-   
Sales per share (Unadj.) Rs1,054.23,553.7-  
Earnings per share (Unadj.) Rs121.9-1,144.7-  
Cash flow per share (Unadj.) Rs190.2374.5-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.714,657.5-  
Shares outstanding (eoy) m166.17332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.73.4 79.6%   
Avg P/E ratio x23.4-10.6 -221.7%  
P/CF ratio (eoy) x15.032.3 46.5%  
Price / Book Value ratio x3.00.8 368.7%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,8314,025,370 11.8%   
No. of employees `00021.716.9 128.1%   
Total wages/salary Rs m33,8020-   
Avg. sales/employee Rs Th8,091.069,939.2 11.6%   
Avg. wages/employee Rs Th1,561.30-   
Avg. net profit/employee Rs Th935.8-22,527.5 -4.2%   
INCOME DATA
Net Sales Rs m175,1701,181,973 14.8%  
Other income Rs m6,20622,603 27.5%   
Total revenues Rs m181,3761,204,576 15.1%   
Gross profit Rs m24,42130,974 78.8%  
Depreciation Rs m11,348505,268 2.2%   
Interest Rs m98368,207 1.4%   
Profit before tax Rs m18,296-519,897 -3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m0132,595 0.0%   
Tax Rs m-1,403-6,589 21.3%   
Profit after tax Rs m20,260-380,714 -5.3%  
Gross profit margin %13.92.6 532.0%  
Effective tax rate %-7.71.3 -605.1%   
Net profit margin %11.6-32.2 -35.9%  
BALANCE SHEET DATA
Current assets Rs m125,991484,783 26.0%   
Current liabilities Rs m72,141428,855 16.8%   
Net working cap to sales %30.74.7 649.7%  
Current ratio x1.71.1 154.5%  
Inventory Days Days7320 373.1%  
Debtors Days Days10566 158.0%  
Net fixed assets Rs m83,854133,793 62.7%   
Share capital Rs m8310-   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,9884,875,085 3.2%   
Long term debt Rs m1,3041,716,694 0.1%   
Total assets Rs m232,2537,620,868 3.0%  
Interest coverage x19.6-6.6 -296.2%   
Debt to equity ratio x00.4 2.4%  
Sales to assets ratio x0.80.2 486.3%   
Return on assets %9.1-4.1 -223.0%  
Return on equity %13.0-7.8 -166.3%  
Return on capital %12.6-4.8 -260.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,841422,274 7.1%  
From Investments Rs m-4,923231,985 -2.1%  
From Financial Activity Rs m-25,159-724,749 3.5%  
Net Cashflow Rs m-266-70,138 0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.87 Rs / USD

Compare DR. REDDYS LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: CADILA HEALTHCARE  WYETH  STERLING BIOTECH  ALEMBIC  ELDER PHARMA  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Apr 20, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS